These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9588267)

  • 1. Clinical presentation and disease associations of gout: a hospital-based study of 100 patients in Singapore.
    Koh WH; Seah A; Chai P
    Ann Acad Med Singap; 1998 Jan; 27(1):7-10. PubMed ID: 9588267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and risk factors of gout flares in a large population-based cohort of incident gout.
    Rothenbacher D; Primatesta P; Ferreira A; Cea-Soriano L; Rodríguez LA
    Rheumatology (Oxford); 2011 May; 50(5):973-81. PubMed ID: 21228059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with recurrent hospital admissions for gout: a case-control study.
    Hutton I; Gamble G; Gow P; Dalbeth N
    J Clin Rheumatol; 2009 Sep; 15(6):271-4. PubMed ID: 19734730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical characteristics, diagnosis and treatment of patients with gout in China].
    Luo H; Fang WG; Zuo XX; Wu R; Li XX; Chen JW; Zhou JG; Yang J; Song H; Duan XJ; Lin XF; Zeng XW; Zeng H
    Zhonghua Nei Ke Za Zhi; 2018 Jan; 57(1):27-31. PubMed ID: 29325307
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of febuxostat in 73 gouty patients with stage 4/5 chronic kidney disease: A retrospective study of 10 centers.
    Juge PA; Truchetet ME; Pillebout E; Ottaviani S; Vigneau C; Loustau C; Cornec D; Pascart T; Snanoudj R; Bailly F; Cornec-Le Gall E; Schaeverbeke T; Saraux A; Dieudé P; Flipo RM; Richette P; Lioté F; Bardin T; Chalès G; Ea HK
    Joint Bone Spine; 2017 Oct; 84(5):595-598. PubMed ID: 27825577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ankylosing spondylitis in Singapore: a study of 150 patients and a local update.
    Koh WH; Boey ML
    Ann Acad Med Singap; 1998 Jan; 27(1):3-6. PubMed ID: 9588266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
    Chohan S; Becker MA; MacDonald PA; Chefo S; Jackson RL
    Arthritis Care Res (Hoboken); 2012 Feb; 64(2):256-61. PubMed ID: 22052584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population.
    Primatesta P; Plana E; Rothenbacher D
    BMC Musculoskelet Disord; 2011 May; 12():103. PubMed ID: 21599917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of gout in the older adult.
    Fravel MA; Ernst ME
    Am J Geriatr Pharmacother; 2011 Oct; 9(5):271-85. PubMed ID: 21849262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gout in systemic lupus erythematosus and overlap syndrome - a hospital-based study.
    Ho HH; Lin JL; Wu YJ; Yu KH; Chen JY; Luo SF
    Clin Rheumatol; 2003 Oct; 22(4-5):295-8. PubMed ID: 14579159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy.
    Drivelegka P; Sigurdardottir V; Svärd A; Jacobsson LTH; Dehlin M
    Arthritis Res Ther; 2018 Jun; 20(1):108. PubMed ID: 29855389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary epidemiology of gout in the UK general population.
    Cea Soriano L; Rothenbacher D; Choi HK; García Rodríguez LA
    Arthritis Res Ther; 2011 Mar; 13(2):R39. PubMed ID: 21371293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence and persistence to urate-lowering therapies in the Irish setting.
    McGowan B; Bennett K; Silke C; Whelan B
    Clin Rheumatol; 2016 Mar; 35(3):715-21. PubMed ID: 25409858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of comorbidities and management of gout in a tropical city in Australia.
    Jeyaruban A; Soden M; Larkins S
    Rheumatol Int; 2016 Dec; 36(12):1753-1758. PubMed ID: 27770227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of inpatients with adverse drug reactions to allopurinol.
    Khoo BP; Leow YH
    Singapore Med J; 2000 Apr; 41(4):156-60. PubMed ID: 11063179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing gout: there's more we can do.
    Mead T; Arabindoo K; Smith B
    J Fam Pract; 2014 Dec; 63(12):707-13. PubMed ID: 25486309
    [No Abstract]   [Full Text] [Related]  

  • 17. Demographic and clinical features of gout patients in Turkey: a multicenter study.
    Öztürk MA; Kaya A; Şenel S; Dönmez S; Balkarlı A; Çobankara V; Erhan Ç; Sayarlıoğlu M; Ugan Y; Tunç ŞE; Pehlivan Y; Kısacık B; Tufan A; Onat AM; Tezcan E; Yıldırım Çetin G; Pamuk ON
    Rheumatol Int; 2013 Apr; 33(4):847-52. PubMed ID: 22588430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients With Early-Onset Gout and Development of Earlier Severe Joint Involvement and Metabolic Comorbid Conditions: Results From a Cross-Sectional Epidemiologic Survey.
    Pascart T; Norberciak L; Ea HK; Guggenbuhl P; Lioté F
    Arthritis Care Res (Hoboken); 2019 Jul; 71(7):986-992. PubMed ID: 30022604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing problem gout.
    Fam AG
    Ann Acad Med Singap; 1998 Jan; 27(1):93-9. PubMed ID: 9588282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical features of gout in a cohort of Italian patients].
    Zampogna G; Andracco R; Parodi M; Cimmino MA
    Reumatismo; 2009; 61(1):41-7. PubMed ID: 19370187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.